TCV Trust & Wealth Management Inc. Has $21.73 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

TCV Trust & Wealth Management Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,483 shares of the healthcare conglomerate’s stock after selling 763 shares during the quarter. UnitedHealth Group makes up approximately 2.0% of TCV Trust & Wealth Management Inc.’s portfolio, making the stock its 11th biggest position. TCV Trust & Wealth Management Inc.’s holdings in UnitedHealth Group were worth $21,727,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $32,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on UNH shares. KeyCorp cut their price target on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a report on Monday, June 2nd. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a report on Friday, June 20th. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. Piper Sandler lowered their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research note on Tuesday, June 3rd. Finally, Barclays lowered their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $415.57.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $308.85 on Friday. The stock has a fifty day simple moving average of $336.21 and a two-hundred day simple moving average of $454.51. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a market cap of $280.17 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the company posted $6.91 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Insider Transactions at UnitedHealth Group

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last three months. Company insiders own 0.28% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.